Related references
Note: Only part of the references are listed.Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
S. Cascinu et al.
ANNALS OF ONCOLOGY (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Adjuvant therapy for adenocarcinoma of the pancreas: Analysis of reported trials and recommendations for future progress
Robert A. Wolff et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis
Nhu-An Pham et al.
BMC CANCER (2008)
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
Veerle F. Casneuf et al.
CANCER INVESTIGATION (2008)
Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
John J. Liang et al.
CLINICAL CANCER RESEARCH (2008)
Coordinated expression of activated mitogen-activated protein kinases in salivary gland adenoid cystic carcinoma
Adriana Handra-Luca et al.
HUMAN PATHOLOGY (2008)
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial
William F. Regine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005)
Michele M. Corsini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)
P. Neuhaus et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins hospital
Joseph M. Herman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma A Series of 30 Patients Collected From 3 Institutions
Mustapha Adham et al.
PANCREAS (2008)
Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer
M. M. Javle et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells
Zhenyu Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NFκB-dependent pathway
Dianren Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive gliorna invasion and progression and predict patient survival
Tim Demuth et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors
Anne Couvelard et al.
GASTROENTEROLOGY (2006)
Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma
Krishdeep S. Chadha et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
E Giovannetti et al.
CANCER RESEARCH (2006)
Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas
A Couvelard et al.
HISTOPATHOLOGY (2005)
Treatment for pancreatic cancer: Current therapy and continued progress
AC Lockhart et al.
GASTROENTEROLOGY (2005)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic significance of phosphorylated p38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma
FJ Esteva et al.
CANCER (2004)
Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors
L Wang et al.
ONCOGENE (2004)
MAP2K4/MKK4 expression in pancreatic cancer: Genetic validation of immunohistochemistry and relationship to disease course
W Xin et al.
CLINICAL CANCER RESEARCH (2004)
Targeting the mitogen-activated protein kinase cascade to treat cancer
JS Sebolt-Leopold et al.
NATURE REVIEWS CANCER (2004)
Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma - Association to aggressive tumor behavior and tumor cell proliferation
A Handra-Luca et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogenactivated protein kinase as a target for therapy
KSJ Elenitoba-Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
MEK/ERK-mediated proliferation is negatively regulated by P38 MAP kinase in the human pancreatic cancer cell line, PANC-1
XZ Ding et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
